Literature DB >> 19140027

From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.

Fred Modell1, Diana Puente, Vicki Modell.   

Abstract

Rationale The objective of these studies was to assess the impact of the Jeffrey Modell Foundation's Physician Education and Public Awareness Campaign (PEPAC) on early diagnosis and management of Primary Immunodeficiencies (PI), and to make available an overview of the data provided by physician experts from the Jeffrey Modell Centers Network (JMCN) of Diagnostic, Research, and Referral Centers worldwide. The Network includes over 304 expert physicians at 138 academic teaching hospitals and medical schools in 39 countries and 120 cities, spanning 6 continents. Methods A survey was sent to the director of each center to ask how many patients were referred, diagnosed, followed, and treated at the centers. Each center was also asked to provide a list of the specific PI defects seen among their patients. Results (i) The PEPAC generated substantial increases in diagnosis, referrals, and treatment of patients with PI disease. (ii) The number of diagnostic tests performed by participating physicians at Jeffrey Modell Centers increased annually by nearly 5 times over a 4 year period. (iii) The number of patients reported with a suspected PI disease totaled 37,544 and 30,283 of these patients were identified with specific PI defects. (iv) The data was sorted and reported in the order of the 43 major PI diseases, and classified by the 8 major PI groups. The data was further organized by the 9 major geographic regions participating and the 15 leading defects by region. (v) The JMCN reports were compared to the European Society for Immunodeficiencies (ESID) registry and there was little difference in the respective percentages for the major immunodeficiency groups. Conclusions These studies provide insight on the number of patients followed, diagnosed, and treated at Jeffrey Modell Centers around the world, the specific PI defect of 30,283 patients, where they were diagnosed and treated, who diagnosed and treated them, and what type of treatment that they are receiving.

Entities:  

Mesh:

Year:  2009        PMID: 19140027     DOI: 10.1007/s12026-008-8092-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  7 in total

Review 1.  Molecular defects in T- and B-cell primary immunodeficiency diseases.

Authors:  Charlotte Cunningham-Rundles; Prashant P Ponda
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

2.  Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies.

Authors:  Diana Pickett; Vicki Modell; Ian Leighton; Fred Modell
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Immunology today and new discoveries: building upon legacies of Dr. Robert A. Good.

Authors:  Fred Modell
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  The impact of physician education and public awareness on early diagnosis of primary immunodeficiencies: Robert A. Good Immunology Symposium.

Authors:  Vicki Modell
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Primary antibody deficiency and diagnostic delay.

Authors:  B Seymour; J Miles; M Haeney
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

Review 6.  Primary immunodeficiencies.

Authors:  Megan A Cooper; Thomas L Pommering; Katalin Korányi
Journal:  Am Fam Physician       Date:  2003-11-15       Impact factor: 3.292

Review 7.  Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.

Authors:  H M Chapel
Journal:  BMJ       Date:  1994-02-26
  7 in total
  22 in total

1.  Neonatal screening for severe combined immunodeficiency.

Authors:  Jennifer M Puck
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

2.  Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.

Authors:  Alice Chan; Christopher Scalchunes; Marcia Boyle; Jennifer M Puck
Journal:  Clin Immunol       Date:  2010-10-28       Impact factor: 3.969

3.  Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.

Authors:  Vicki Modell; Bonnie Gee; David B Lewis; Jordan S Orange; Chaim M Roifman; John M Routes; Ricardo U Sorensen; Luigi D Notarangelo; Fred Modell
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

4.  Development of Primary Immunodeficiencies in Africa.

Authors:  A A Bousfiha; L Jeddane; N Erwa; T N Dieye; F Mellouli; S M Reda; M Esser; R Boukari
Journal:  J Clin Immunol       Date:  2015-05       Impact factor: 8.317

5.  Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign.

Authors:  Andrew A Harrison; Christoffel Badenhorst; Sandra Kirby; Douglas White; Josie Athens; Simon Stebbings
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

6.  Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.

Authors:  Daniela S Rajao; Crystal L Loving; Emily H Waide; Phillip C Gauger; Jack C M Dekkers; Christopher K Tuggle; Amy L Vincent
Journal:  J Innate Immun       Date:  2016-12-17       Impact factor: 7.349

7.  Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.

Authors:  Aristoteles Alvarez-Cardona; Sara Elva Espinosa-Padilla; Saul Oswaldo Lugo Reyes; Javier Ventura-Juarez; Jaime Asael Lopez-Valdez; Lucila Martínez-Medina; Alberto Santillan-Artolozaga; Adriana Cajero-Avelar; Alma R De Luna-Sosa; Luis F Torres-Bernal; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2016-02-22       Impact factor: 8.317

Review 8.  The case for newborn screening for severe combined immunodeficiency and related disorders.

Authors:  Jennifer M Puck
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

9.  Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa.

Authors:  Reené Naidoo; Lisa Ungerer; Margaret Cooper; Sandra Pienaar; Brian S Eley
Journal:  J Clin Immunol       Date:  2010-09-22       Impact factor: 8.317

10.  Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.

Authors:  Vicki Modell; Jessica Quinn; Jordan Orange; Luigi D Notarangelo; Fred Modell
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.